Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA
A clinical trial evaluating an implantable cardiac monitor to detect atrial fibrillation in patients with myocardial infarction with nonobst…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study [NA]
The LockeT II study is an ongoing trial evaluating vascular closure with a device versus manual compression after atrial fibrillation ablati…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF [NA]
Clinical trial update on weight management using GLP-1 receptor agonists to influence ablation outcomes in overweight/obese patients with ty…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Atrial Fibrillation Duration and Cortical Lens Opacity
A completed clinical trial update investigating the relationship between atrial fibrillation duration and the development of cortical catara…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: The Modified "Pills-in-the-Pocket" Strategy [NA]
A clinical trial update indicates that a modified 'pills-in-the-pocket' strategy for atrial fibrillation is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Hybrid Therapy and Heart Team for Atrial Fibrillation [NA]
Clinical trial update indicating recruitment for a study on hybrid therapy and Heart Team management for atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy. [NA]
This clinical trial update reports the results of a two-staged ECG-I targeted ablation strategy for persistent atrial fibrillation not respo…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: ECG-I Targeted Ablation for Persistent AF [NA]
This update notes the completed status of a clinical trial evaluating ECG-I targeted ablation for persistent atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: ECG-I Phenotyping of Persistent AF Based on Driver Distribution to Predict Response to Pulmonary Vein Isolation [NA]
A completed clinical trial evaluating ECG-I phenotyping of persistent atrial fibrillation based on driver distribution to predict response t…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: The Role of Multimodality Imaging in Left Atrial Appendage Closure [NA]
This clinical trial update reviews how multimodality imaging is used to guide left atrial appendage closure in atrial fibrillation; the stud…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Predicting Disease Progression in Atrial Fibrillation: A Multiparametric Approach for Prognostic Marker Identification and Personalized Patient Management
This clinical trial explores multiparametric prognostic markers to predict disease progression in atrial fibrillation and to support persona…
-
FDA approval · 2024-10-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic diltiazem hydrochloride under an Original Application (ANDA).
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men [NA]
This clinical trial is evaluating whether atrial fibrillation ablation can prevent progression of AF-induced atrial cardiomyopathy in both w…
-
FDA approval · 2024-10-17FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Propafenone Hydrochloride filed by Strides Pharma Science Limited, adding a approved generic…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation [Phase 4]
A Phase 4 clinical trial update examining P2Y12 inhibitor monotherapy in patients with atrial fibrillation undergoing Supraflex stent implan…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Utility of Analyzing Atrial Signal Electrograms in Patients with Atrial Fibrillation Using Next-Generation Ensite X Software: a Prospective Study
A prospective study evaluates using next-generation Ensite X software to analyze atrial signal electrograms in patients with atrial fibrilla…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Comparison of 3 RF Delivery Modes of the QDOT Catheter for Paroxymal Atrial Fibrillation (AF) Ablation [NA]
An ongoing clinical trial evaluating three RF delivery modes of the QDOT catheter for ablation of paroxysmal atrial fibrillation; the study …
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Waveform Periodicity Analysis in Patients With Persistent Atrial Fibrillation [NA]
A clinical trial update indicates that a study on waveform periodicity analysis in patients with persistent atrial fibrillation is currently…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action. [NA]
A recruiting clinical trial evaluating a therapeutic garden–based, multidisciplinary primary care intervention for cardio-neurovascular cond…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
A clinical trial registry update for the LOCATE Registry, a long-term evaluation of cardiac arrhythmias after transcatheter aortic valve imp…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Study For Treatment Of Paroxysmal Atrial Fibrillation (PAF) With The THERMOCOOL SMARTTOUCH SF Catheter and TRUPULSE Generator [NA]
ClinicalTrials.gov entry reports a completed study evaluating the ThermoCool SmartTouch SF catheter with the TRUPULSE Generator for paroxysm…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: CLOSE Versus High Density Mapping Guided Catheter Ablation of Paroxysmal Atrial Fibrillation [NA]
This update reports completion of the trial comparing CLOSE high-density mapping-guided catheter ablation versus high-density mapping in pat…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
An observational study evaluating procedural aspects and outcomes of AF ablation using the STAR Apollo mapping system; the trial is currentl…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Zenith LAA Occlusion System [NA]
This clinical trial update indicates AuriGen Medical's Zenith LAA Occlusion System is currently recruiting for use in atrial fibrillation pa…
-
FDA approval · 2024-10-15FDA Approved: ESMOLOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA supplemental approval for Amneal's esmolol hydrochloride in sodium chloride, a generic injectable product.